Global Drug-Coated Balloons Market is Likely to Grow at a CAGR Value of 15.1% By 2028

The global drug-coated balloons market size was worth around USD 782.4 million in 2021 and is estimated to grow to about USD 1,819.2 million by 2028, with a compound annual growth rate (CAGR) of approximately 15.1% over the forecast period. The report analyzes the drug-coated balloons market's drivers, restraints/challenges, and their effect on the demands during the projection period. In addition, the report explores emerging opportunities in the drug-coated balloons market.

A semi-compliant angioplasty balloon coated with a cytotoxic chemotherapeutic substance is known as a drug-coated balloon (DCB). Balloons with paclitaxel coating are becoming more common in commercial settings. Drug-coated balloons have evolved as an innovative method in recent years that was created to address the drawbacks of drug-coating stents and is anticipated to be successful under challenging subgroups. Recently, preclinical and clinical investigations estimated the number of drug-coated balloons found for coronary and peripheral uses, with positive findings.

Rising technical development and interest in minimally invasive surgery are expected to drive the global drug-coated balloons market. One of the key factors influencing the market is the rising incidence of peripheral and coronary artery disorders worldwide. Other important factors influencing the market growth include the rapidly growing geriatric population with cardiovascular diseases, the enormous patient base in developing nations, and cumulative investments in R&D for treating peripheral and coronary artery disorders. However, because of the high cost of methods and commodities, as well as strict regulatory requirements, it is anticipated that the global market for drug-coated balloons will grow slowly.

The global drug-coated balloons market is segregated based on indication, drug type, end-user, and region. Based on indication, the market is divided into peripheral artery disease (PAD), coronary artery disease (CAD), and others. The PAD category accounted for more than 81% of the market in 2021, and it is likely to maintain its dominance throughout the forecast period. Based on drug type, the market is divided into paclitaxel and sirolimus. Paclitaxel devices have the highest market share because they are safe and effective in treating cardiovascular diseases, aortic valve diseases, and urological problems. Based on end-user, the market is divided into hospitals, ambulatory care settings, and freestanding cath labs. The hospital category is expanding at a healthy rate as a result of the widespread use of DCBs of the most recent generation.

The global drug-coated balloons market is segmented into geographic regions of North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America dominates the market for drug-coated balloons worldwide. The main reason for the high market share is the existence of a significant disease population, coupled with better access to treatment. With the new product approvals, expanded indication approvals for commercially available DCBs, the availability of a wealth of clinical evidence, and the approval of new products, the North American market is anticipated to have profitable growth during the projection period. 

Heart disease is more likely to affect elderly adults, especially those with weakened immune systems and significant chronic health issues. The Asia Pacific drug coating balloon market is anticipated to provide significant potential over the course of the projected period due to the region's aging population, desire for improved quality care, and growth in the prevalence of cardiovascular disorders. With its growing geriatric population, cardiovascular illnesses and diseases are becoming more prevalent in China. Government-sponsored research projects are supporting and reshaping the country's healthcare system. Some more reasons influencing demand in China are the rise in medical tourism, and the rapidly expanding healthcare infrastructure.

Key players functioning in the global drug-coated balloons market include Aachen Resonance, Acotec Scientific, AR Baltic Medical, Biosensors International Group, BIOTRONIK, Cardionovum, Concept Medical, Eucatech, ENDOCOR, HEXACATH, iVascular, M.A. Med Alliance, Meril Life Sciences, Nano Therapeutics, QT Vascular, RD Global-Invamed, STENTYS, Surmodics, Terumo, Urotronic, and Welling.

Recent developments:

• In May 2022, MedAlliance's SELUTION SLR Drug-eluting Balloon received FDA Investigational Device Exemption approval. Similar to a drug-eluting stent, the innovative sirolimus-eluting balloon known as the SELUTION SLR (Sustained Limus Release) delivers a controlled and sustained drug release. On March 4, 2019, and again on September 25, 2019, the FDA awarded "Breakthrough Device Designation" to SELUTION SLR, the first drug-eluting balloons (DEB), for below-the-knee (BTK) applications in peripheral artery disease.
• In June 2020, Essential Pro, a revolutionary coronary artery drug-coated balloon, was launched globally by iVascular SLU (DCB). From its predecessor, the Essential Pro DCB offers a number of platform enhancements, including increased safety with quick deflation times due to an expansion of the inflating channel and the availability of two alternative shafts.

Browse the full “Drug-Coated Balloons Market By Indication (PAD, CAD, and Others), By Drug Type (Paclitaxel and Sirolimus), By End-User (Hospitals, Ambulatory Care Settings, and Freestanding Cath Labs), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028.” Report at https://www.zionmarketresearch.com/report/drug-coated-balloons-market

Global Drug-Coated Balloons Market is segmented as follows:

By Indication

• PAD
• CAD
• Others

By Drug Type

• Paclitaxel
• Sirolimus

By End-user

• Hospitals
• Ambulatory Care Settings
• Freestanding Cath Labs

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com